You may take your dose with or without food. The recommended length of treatment with Zepatier is 12 to 16 weeks.
Treatment is usually 8-12 weeks long but can be as much as 16 weeks long in certain situations. Some patients with more damage to their liver may require 24 weeks of treatment, but this is uncommon. The duration depends on the medication, and specific HCV factors in particular patients.
How is Harvoni used? Harvoni is taken once daily, with or without food, for 8 to 24 weeks. Treatment length depends on HCV treatment history, whether a person has cirrhosis, and the amount of hepatitis C virus in a person's bloodstream (called HCV RNA or viral load).
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.
Recent advances in antiviral treatment have led to the development of new highly effective drugs for the treatment of all types of hepatitis C. The new hepatitis C treatments are sofosbuvir with ledipasvir (Harvoni); sofosbuvir (Sovaldi); daclatasvir (Daklinza); and ribavirin (Ibavyr).
Symptoms of end-stage liver disease may include:Easy bleeding or bruising.Persistent or recurring yellowing of your skin and eyes (jaundice)Intense itching.Abdominal pain.Loss of appetite.Nausea.Swelling due to fluid buildup in your abdomen and legs.Problems with concentration and memory.
The more common side effects of Harvoni can include:fatigue.headache.nausea.diarrhea.insomnia (trouble sleeping)cough.weakness.muscle pain.More items...
Hepatitis C is treated using direct-acting antiviral (DAA) tablets. DAA tablets are the safest and most effective medicines for treating hepatitis C. They're highly effective at clearing the infection in more than 90% of people. The tablets are taken for 8 to 12 weeks.
A more serious side effect of Harvoni is bradycardia (slow heart rate)....Circulatory systemfeeling like you're going to faint, or actually fainting.lightheadedness.tiredness.weakness.shortness of breath.chest pains.confusion or memory problems.
Most people don't experience significant side-effects – but if they do the most common adverse reactions observed with treatment with Zepatier for 12 weeks are headache, nausea, diarrhea, sleep problems (Insomnia) and fatigue.
Infants and children are more likely to develop a chronic (long-lasting) hepatitis B infection. A vaccine can prevent hepatitis B, but there's no cure if you have the condition. If you're infected, taking certain precautions can help prevent spreading the virus to others.
Hepatitis B is a liver infection caused by a virus (called the hepatitis B virus, or HBV). It can be serious and there's no cure, but the good news is it's easy to prevent.
How long does Mavyret take to work? Studies show Mavyret cures hepatitis C in most people within 8 to 16 weeks when it's taken as directed. After that time period, your doctor will order blood tests to see if you still have hepatitis C.
Hepatitis C infection is cured if the virus is undetectable 12 weeks after the completion of a course of direct-acting antiviral treatment. This is known as a sustained virologic response (SVR).
But Bacon says hepatitis C treatment can have side effects "that are akin to what patients experience when they receive cancer chemotherapy." That includes temporary hair loss. The peginterferon-ribavirin combination is "sometimes loosely called chemotherapy," says Bacon.
After many years some people will have minimal liver damage with no scarring while others can progress to cirrhosis (extensive scarring of the liver) within less than ten years. On average it takes about twenty years for significant liver scarring to develop.
You should not use Zepatier if you are allergic to elbasvir or grazoprevir, or if you have: 1. moderate or severe liver disease.If you take Zepatie...
Take Zepatier exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not use this medicine in larger or smaller...
Usual Adult Dose of Zepatier for Chronic Hepatitis C:1 tablet orally once a dayRecommended Regimen and Duration of Therapy:-Genotype 1a, therapy-na...
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to...
Taking this medication will not prevent you from passing hepatitis C to other people. Do not have unprotected sex or share razors or toothbrushes....
When you start or stop taking Zepatier, your doctor may need to adjust the doses of any other medicines you take on a regular basis.Many drugs can...
Take Zepatier exactly as prescribed by your doctor. Your doctor will perform blood tests to make sure you do not have conditions that would prevent you from safely using Zepatier.
Zepatier contains a combination of elbasvir and grazoprevir. Elbasvir and grazoprevir are antiviral medicines that prevent hepatitis C (HCV) from multiplying in your body.
When you start or stop taking Zepatier, your doctor may need to adjust the doses of any other medicines you take on a regular basis.
What are the new drugs for the treatment of hepatitis C? The newest drugs for the treatment of hepatitis C include Mavyret (glecaprevir and pibrentasvir), Vosevi (sofosbuvir, velpatasvir, and voxilaprevir), and Epclusa (sofosbuvir and velpatasvir).
seizure medicine - carbamazepine, phenytoin. if you use a blood thinner ( warfarin, Coumadin, Jantoven) and you have routine "INR" or prothrombin time tests. Zepatier is sometimes used in combination with ribavirin. Both men and women using ribavirin should use effective birth control to prevent pregnancy.
shortness of breath. Common Zepatier side effects may include: headache; tiredness; anemia; or. nausea.
Get emergency medical help if you have signs of an allergic reaction to Zepatier: hives; difficult breathing; swelling of your face, lips, tongue, or throat. In rare cases, Zepatier may cause serious liver injury. Tell your doctor right away if you have symptoms such as:
Zepatier is a beige pill, taken once daily, with or without food, for 12 or 16 weeks. Some people will need to take another drug with Zepatier, called ribavirin (RBV), twice daily.
For people taking Zepatier for 16 weeks, another blood test is recommended at 12 weeks after starting treatment .
In clinical trials, the most common side effects from Zepatier were fatigue and headache, nausea, insomnia, and diarrhea. People taking RBV also experienced anemia, shortness of breath, rash, itching, depression, irritability, and achy joints (see TAG’s ribavirin (RBV) fact sheet for more information). Most of these side effects were mild.
Zepatier comes in a 14-pill blister pack; each pill is individually packaged to protect Zepatier from moisture. Keep Zepatier in the packaging until you take it.
In clinical trials, people over 65 years old, women, and people of Asian ancestry had higher levels of Zepatier in their bloodstream and were more likely to have liver enzyme elevations.
The goal of hepatitis C virus (HCV) treatment is a cure (when there is no hepatitis C virus in a person’s bloodstream at least 12 weeks after treatment is finished).
It is not known whether Zepatier causes harm to unborn babies. If you are pregnant, or planning pregnancy, talk with your health care provider about the risks and benefits of HCV treatment.
ZEPATIER is a two-drug, fixed-dose combination product containing 50 mg of elbasvir and 100 mg of grazoprevir in a single tablet. The recommended dosage of ZEPATIER is one tablet taken orally once daily with or without food [see Clinical Pharmacology (12.3)].
Patients who have failed treatment with PegIFN + RBV + HCV NS3/4A protease inhibitor (PI): boceprevir, simeprevir, or telaprevir.
No dosage adjustment of ZEPATIER is recommended in patients with any degree of renal impairment including patients on hemodialysis. Administer ZEPATIER with or without ribavirin according to the recommendations in Table 1 [see Use in Specific Populations (8.8) and Clinical Studies (14.4)]. Refer to the ribavirin tablet prescribing information for the correct ribavirin dosage for patients with CrCl less than or equal to 50 mL per minute.
It's one of the first choice treatment options for hepatitis C genotypes 1 and 4.
Zepatier (elbasvir / grazoprevir) comes in a blister pack of individual pills. The tablets are sensitive to moisture so keep the tablets in this package until you are ready to take one.
With any medication, there are risks and benefits. Even if the medication is working, you may experience some unwanted side effects.
There is currently no generic for Zepatier (elbasvir / grazoprevir), so it can be expensive, even with insurance. GoodRx coupons, copay cards and patient assistance programs may help lower the cost.
Zepatier (elbasvir / grazoprevir) contains 2 antiviral medications that work together to stop the hepatitis C virus from making copies of itself in the body.
This is how they will monitor your liver and make sure the medication is working against the virus. An important lab called "SVR" will be drawn 12 weeks after you have stopped the medication. The results of this lab will determine if you have been cured of hepatitic C.
Zepatier (elbasvir / grazoprevir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options
Zepatier (ZEP-ah-teer) is a fixed-dose combination of elbasvir and grazoprevir ( Figure 1) and ( Figure 2 ). It is manufactured by Merck & Co., Inc.
No dosage adjustment is recommended for elbasvir-gra zoprevir in patients with renal insufficiency, including patients with end-stage renal disease or patients on hemodialysis. For patients with mild hepatic impairment (Child-Pugh Class A), no dose adjustment of elbasvir-grazoprevir is recommended.
Signs of liver problems. ZEPATIER may cause increases in your liver-related blood tests. This could be a sign of serious liver problems. Your healthcare provider will do blood tests to check your liver before and during treatment with ZEPATIER. Tell your healthcare provider right away if you get any of the following symptoms or if they get worse during treatment with ZEPATIER:
Medicines are sometimes prescribed for purposes other than those listed in the patient information. Do not use ZEPATIER for a condition for which it was not prescribed. Do not give ZEPATIER to other people, even if they have the same condition. It may harm them.
The standard length of treatment is 12 to 24 weeks, depending on genotype, viral load, liver condition and prior treatment experience and response. In some cases, 8 weeks may be considered in patients without cirrhosis who have pre-treatment HCV RNA (viral load count) less than 6 million IU/mL.
Viekira Pak for 12 weeks (w/o cirrhosis) or use with Ribavirin for 12 weeks (with cirrhosis)
UT Southwestern Clinical Center for Liver Disease states it typically takes four weeks to get insurance approval and receive the medications. Even if you have given interferon injections and taken ribavirin in the past, you must attend the nurse teaching session based on the dosing schedule, and receive information on drug interactions and side effects. Patients can receive their first dose at the end of the mandatory nurse teaching session.
Patients can receive their first dose at the end of the mandatory nurse teaching session. If possible, it is good to take a family member or friend with you to the teaching session, write down your questions and the answers. They can help support you and also learn what to expect with the treatment.
People with genotype 1a without these mutations and those with genotype 1b who were previously unsuccessfully treated with pegylated interferon and ribavirin (abbreviated as ‘IFN/RBV’ in the table below) can take Zepatier alone for 12 weeks.
In the C-SURFER trial, 94% of hepatitis C patients with severe kidney impairment using Zepatier alone for 12 weeks were cured. The study included both previously untreated and treatment-experienced people.
For previously untreated people with HCV genotype 4, the combined cure rate using Zepatier alone for 12 weeks was 97% in three studies, again including patients with cirrhosis and HIV-positive participants. The response rate was 100% for the small number of people with genotype 4 HCV who used Zepatier plus ribavirin for 16 weeks in the C-EDGE treatment-experienced trial.
Most people who have not taken HCV treatment before and who have HCV genotype 1 or 4, with or without liver cirrhosis, will be able to take Zepatier without ribavirin for 12 weeks.
Zepatier is a new medication used to treat hepatitis C. It is a combination pill containing grazoprevir plus elbasvir. It was approved in Europe in July 2016 for treatment of adults with genotype 1 or 4 chronic hepatitis C.
The drugs in Zepatier are generally safe and well tolerated. The most common side-effects seen in clinical trials were fatigue, headache and nausea. A small number of study participants developed elevated levels of the liver enzyme ALT because of grazoprevir. If there are high ALT elevations and/or other signs of possible liver toxicity such as nausea, yellow eyes or skin, patients should urgently consult with their doctors. Ribavirin can cause other side-effects including anaemia (low haemoglobin level).
Zepatier is not approved for people with HCV genotypes 2, 3, 5 or 6.